Skip to main content

Is Sunosi (solriamfetol) a controlled substance?

Medically reviewed by Drugs.com. Last updated on Sep 2, 2024.

Official Answer by Drugs.com

Yes. Sunosi (solriamfetol) is a Schedule IV Controlled Substance in the United States.

Sunosi (solriamfetol) is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA). It was approved by the FDA in March 2019.

Sunosi is a federally controlled substance (CIV) because it contains solriamfetol, which has the potential for abuse.

Sunosi should always be stored in a safe place to protect it from theft. Any unused or expired Sunosi should be disposed of via a medication take-back program, or mixed with an undesirable substance and thrown away in the household trash.

Read next

How do I know if I have sleep apnea? The warning signs

Warning signs of obstructive sleep apnea (OSA)  include loud snoring, pauses in breathing during sleep, gasping or choking sounds during sleep and frequent awakenings at night. Mornings headaches, a dry mouth or sore throat and excessive daytime drowsiness may also occur. Often, a sleep partner may notice these signs at night.

Continue reading

Is sleep apnea the hidden cause of your high blood pressure?

Sleep apnea is a common but often hidden cause of high blood pressure. It contributes to hypertension through multiple mechanisms and is especially prevalent in people whose blood pressure is difficult to control. Left untreated, high blood pressure can lead to many serious complications.

Continue reading

Zepbound Vs Mounjaro: Complete Comparison Guide for Weight Loss and Diabetes Treatment

Comprehensive comparison of Zepbound vs Mounjaro. Learn about their uses, dosing, effectiveness, costs, and safety profiles to understand which medication might be right for you. Continue reading

See also:

Related medical questions

Drug information

Related support groups